Generate Biomedicines (GENB) EV/EBITDA: History & Chart

Generate Biomedicines, Inc.(GENB)

Biotechnology · Somerville, MA

$13.80-0.11 (-0.79%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Generate Biomedicines, Inc.

Generate Biomedicines, Inc. is a U.S.-based company pioneering generative biology, leveraging machine learning for the discovery and advancement of novel protein therapeutics. Their core approach involves developing drugs using protein-based modalities. The company's pipeline includes several key candidates: GB-0895, an investigational long-acting anti-TSLP monoclonal antibody designed for bi-annual dosing in severe asthma; GB-4362, an MMAE payload neutralizer monoclonal antibody; and GB-5267, a MUC16 CAR-T cell therapy. Integral to their work is the Generate Platform, a sophisticated system engineered to be versatile across diverse therapeutic areas and protein modalities. This platform combines computational innovation with scalable biohardware, allowing them to tackle therapeutic hurdles beyond the capabilities of traditional technologies. Established in 2018, the company was initially known as Generate Biologics, Inc. before rebranding to Generate Biomedicines, Inc. in February 2020. Its headquarters are located in Somerville, Massachusetts.

Somerville, MA

312 employees

generatebiomedicines.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Michael T. Nally

View full financials

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
Generate Biomedicines, Inc. (GENB)	$1.77B	N/A	N/A	N/A	N/A
Surgery Partners, Inc. (SGRY)vs ›	$1.75B	9.62x	10.11x	12.56x	13.71x
Novocure Ltd (NVCR)vs ›	$1.74B	N/A	2603.44x	1662.57x	1662.57x
Absci Corporation (ABSI)vs ›	$1.74B	N/A	N/A	N/A	N/A
Xeris Biopharma Holdings, Inc. (XERS)vs ›	$1.74B	38.84x	89.00x	147.22x	147.22x
Alignment Healthcare, Inc. (ALHC)vs ›	$1.74B	15.87x	130.62x	220.82x	220.82x
Xencor, Inc. (XNCR)vs ›	$1.81B	N/A	26.29x	37.47x	47.79x
LeMaitre Vascular, Inc. (LMAT)vs ›	$1.81B	21.67x	30.23x	32.57x	30.28x
Intellia Therapeutics, Inc. (NTLA)vs ›	$1.73B	N/A	N/A	N/A	N/A
Azenta, Inc. (AZTA)vs ›	$1.81B	49.01x	24.79x	97.87x	107.08x

NAME

MARKET CAP

EV/EBITDA RATIO

TTM

Generate Biomedicines, Inc. (GENB)

$1.77B

N/A

Surgery Partners, Inc. (SGRY)vs ›

$1.75B

9.62x

10.11x

12.56x